GenMark Diagnostics to Present at the 2016 J.P. Morgan Healthcare Conference
December 30 2015 - 1:05PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will
present at the 2016 J.P. Morgan Healthcare Conference to be held at
the Westin St. Francis Hotel in San Francisco, California on
Wednesday, January 13, 2016. The presentation will be delivered by
Hany Massarany, President and Chief Executive Officer, and is
scheduled to begin at 3:00 pm Pacific Time. The presentation will
be made available at http://ir.genmarkdx.com/.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark's proprietary
eSensor® detection technology, GenMark's eSensor
XT-8TM system is designed to support a broad range of
molecular diagnostic tests with a compact, easy-to-use workstation
and self-contained, disposable test cartridges. The eSensor
detection technology is also incorporated into GenMark's
sample-to-answer system, ePlexTM. For more information,
visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151230005049/en/
GenMark Diagnostics, Inc.Hany MassaranyPresident, Chief
Executive Officer760-448-4325
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024